What s new in breast cancer research? SABCS 2023 takeaways | Fred Hutchinson Cancer Center fredhutch.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fredhutch.org Daily Mail and Mail on Sunday newspapers.
After receiving diversity, equity, and inclusion (DEI) training, fellows at Yale s medical school say they felt more comfortable dealing with racial inequality and sexual harassment.
Thomas Duffy, MD, professor emeritus of medicine (hematology) at Yale School of Medicine and Yale Cancer Center, served as director of the Hematology Fellowship
Study reveals blood tests can offer early indicator of severe COVID-19 ANI | Updated: Mar 02, 2021 09:44 IST
Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19patients.
The findings of the study were published in the journal Blood Advances .
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. However, this study focuses on biomarkers that can help predict severe outcomes in COVID-19patients.
Read Time:
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery.
New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. Patients with high levels of these markers were much more like to require care in the intensive care unit, require ventilation, or die due to their COVID-19, said Dr. Hyung Chun, the lead author, an associate professor of medicine in cardiovascular medicine and pathology and director of translational research at the Yale Pulmonary Vascular Disease Program.